Delivery Order SPE2DB24D1107-SPE2DB24FZEF9
Award Date
5/6/24
Potential Completion Date
5/7/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $8,456.60, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a completion date of February...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $41,648.94, is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract has an ultimate completion date of September 27, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FM0T9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,222.12 firm fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml pen 2 ml, with a completion date of December 28, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award, with a ceiling value of $5,005.47, is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product. The contract has an ultimate completion date of April 29, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $22,954.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the pharmaceutical product Dupixent 300 mg/2 ml pen, with a completion date of December 8, 2023. The contract was awarded on December 7, 2023 and is a firm fixed-price contract. This award is not associated with any set-aside designation, indicating it was awarded through full...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FZ05M, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $22,112.30 and is for the delivery of pharmaceutical products, including the medication Dupixent 300 mg/2 ml pen. The contract has a firm fixed price pricing type and an ultimate completion date of December 1, 2023. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pen. The contract, valued at $48,857.86, is a delivery order with a firm fixed price structure and an ultimate completion date of September 6, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...
This federal contract award, identified as SPE2DB22D3016|SPE2DB24FAPR1, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Dupixent 300 mg/2 ml pen medication, with an ultimate completion date of March 11, 2024 and a ceiling value of $20,341.64. This is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,957.03 firm-fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml pen with an ultimate completion date of April 25, 2023. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., from the Defense Logistics Agency (DLA). The contract, valued at $5,002.22, is a delivery order for the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract has an ultimate completion date of April 26, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...